CLINICAL_TRIALS
trial_result
· 2023-09-21
Clinical Trial Update: A Model About the Response of Belimumab in SLE [Phase 4]
Summary
Phase 4 trial update exploring belimumab in systemic lupus erythematosus.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: First Affiliated Hospital Xi'an Jiaotong University | Conditions: Systemic Lupus Erythematosus | Phase 4 | Status: UNKNOWN